Marc T. Roth, MD

Marc Roth, MD, is a fellowship-trained hematology oncologist. Dr. Roth is board certified in internal medicine, medical oncology, and hematology.

Dr. Roth believes a successful treatment plan must be personalized to treat the patient's physical and emotional needs, as well as their specific cancer.

His areas of clinical interest include gastroesophageal, hepatobiliary, pancreatic, colorectal, and anal malignancies. He is also interested in clinical trial development, precision medicine, and the microbiome.

Abstracts:
https://meetings.asco.org/abstracts-presentations/201267
https://meetings.asco.org/abstracts-presentations/182311
https://meetings.asco.org/abstracts-presentations/182468

Original Articles:
1. Ahrin ND, Shen C, Bailey CE, Matsuoka LK, Hawkins AT, Holowatyj AN, Ciombor KK, Hopkins MB, Geiger
TM, Kam AE, Roth MT, Lee CML, Lapelusa M, Dasari A, Eng C. Surgical resection and survival outcomes in metastatic young adult colorectal cancer patients. Cancer Med. 2021 June 16. PMID: 34132476.
2. Roth MT, Das S. Pembrolizumab in unresectable or metastatic MSI-high colorectal cancer: safety and efficacy. Expert Rev Anticancer Ther. 2021 Feb 21. PMID: 33183114.
3. Roth MT, Cardin DB, Borazanci EH, Steinbach M, Picozzi VJ, Rosemury A, Wadlow RC, Newman RA, Berlin J.A Phase II, Single-Arm, Open-Label, Bayesian Adaptive Efficacy and Safety Study of PBI-05204 in Patients with Stage IV Metastatic Pancreatic Adenocarcinoma. Oncologist. 2020 May 26. PMID: 32452588.
4. Roth MT, Cardin DB, Berlin JD. Recent advances in the treatment of pancreatic cancer. F1000Res. 2020 Feb 21. PMID: 32148767.
5. Iams WT, Shiuan E, Meador CB, Roth M, Bordeaux J, Vaupel C, Boyd KL, Summitt IB, Wang LL, Schneider JT, Warner JL, Zhao Z, Lovly CM. Improved Prognosis and Increased Tumor-Infiltrating Lymphocytes in Patients Who Have SCLC With Neurologic Paraneoplastic Syndromes. J Thorac Oncol. 2019 Jun 12. PMID: 31201935.
6. Roth MT, Goff LW. Gemcitabine, Cisplatin, and nab-Paclitaxel for Patients With Advanced Biliary Tract Cancer: Closing the GAP. JAMA Oncol. 2019 Jun 1. PMID: 30998823.
7. Roth MT, Berlin JD. Current Concepts in the Treatment of Resectable Pancreatic Cancer. Curr Oncol Rep. 2018 Mar 26. PMID: 29582218.
8. Roth MT, Goff LW. Adjuvant Therapy for Biliary Tract Cancers Advance. Oncology Live. 2017;18(23).
9. He M, Crow J, Roth M, Zeng Y, Godwin AK. Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology. Lab Chip. 2014 Oct 7. PMID: 25099143.

Book Chapters
1. Roth MT, Ciombor KK. ‘Colorectal Cancer’ in Ginsburg, G & Willard, H. Genomic and Precision Medicine, 3 rd edition. Elsevier, Volume 2, Chapter 15.
2. Roth MT, Goff LW. 'Sequencing of Systemic Chemotherapy for Unresectable CRLM' in Correia, MM. Colorectal Cancer Liver Metastases: A Comprehensive Guide to Management. Springer, Chapter 23. 2020.